CD4 and neoplasm: Although tumor-reactive CD4+ effector/helper T cells are increasingly recognized as critical determinants of effective antitumor immune responses, the effect of chemotherapy on these cells is largely neglected, and the role of CD4+ T cells in modulating postchemotherapy host immunity is almost entirely unknown.